Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025

In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting organizations to seek innovative commercialization strategies for their drugs and devices. Additionally, the growing focus on patient-centricity and customer experience has accelerated outsourcing to specialized providers.
Providers are essential in this transformation. They offer expertise in generative AI, advanced analytics, and AI/ML, to streamline workflows and maximize efficiency. In response to market needs, they have expanded their portfolios to offer comprehensive, end-to-end solutions supporting pre-launch and post-launch commercialization activities.
In this report, we assess 30 providers featured on the Life Sciences AI and Analytics Commercial Services PEAK Matrix® Report. Each provider profile highlights the service focus, key IP/solutions, domain-specific investments, and case studies.